Sunday, November 13, 2016
- 9:00AM-11:00AM
-
Abstract Number: 715
Are Patients with Ankylosing Spondylitis Willing to Pay for Treatment with Infliximab?
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment- 9:00AM-11:00AM
-
Abstract Number: 436
Are Providers Recommending Appropriate Screening for Hydroxychloroquine-Induced Retinal Toxicity to Their Patients?
Quality Measures and Quality of Care - Poster I- 9:00AM-11:00AM
-
Abstract Number: 161
Are Ultrasound Definitions in Gout Reliable?: Preliminary Results from a Latin American Reliability Exercise
Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies- 9:00AM-11:00AM
-
Abstract Number: 863
Arterial Lesions in Giant Cell Arteritis
Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 74
Arthritis-Associated DNA Hypermethylation Provokes Increased Antibody Expression in Mouse Model of Rheumatoid Arthritis
Genetics, Genomics and Proteomics - Poster I- 9:00AM-11:00AM
-
Abstract Number: 691
ASAS Health Index for Patients with Spondyloarthritis: Translation into Spanish, Validation, Reliability and Construct Validity
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment- 9:00AM-11:00AM
-
Abstract Number: 159
Assessing Agreement Among Measures of Inflammation Detected on Magnetic Resonance Imaging, Ultrasound and Clinical Findings in the Feet of Patients with Early Rheumatoid Arthritis
Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies- 9:00AM-11:00AM
-
Abstract Number: 605
Assessment of Comparative Immunogenicity in Biosimilar Development: Immunogenicity and Pharmacokinetics Following a Single Dose of M923, a Proposed Biosimilar for Reference Adalimumab (HUMIRA®), Compared with US- and EU-Sourced Reference Adalimumab in Healthy Subjects
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster I- 9:00AM-11:00AM
-
Abstract Number: 339
Assessment of High-Resolution Peripheral Quantitative Computed Tomography Parameters and Markers of Bone Metabolism in Community-Dwelling Elderly with and without Vertebral Fractures – the Sao Paulo Ageing & Health Study
Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster- 9:00AM-11:00AM
-
Abstract Number: 528
Assessment of Metacarpal Head Bone Microarchitecture According to Presence or Not of Inflammation in Rheumatoid Arthritis Patients with Low Disease Activity
Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis- 9:00AM-11:00AM
-
Abstract Number: 143
Assessment of Patient Satisfaction, Functionality and Quality of Life after Ultrasound Guided Knee Intervention: A Prospective Study Tejas Sheth, MD. Beverly Johnson, MD, MS. Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY
Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies- 9:00AM-11:00AM
-
Abstract Number: 790
Assessment of the Construct Validity of the Lupus Low Disease Activity State (LLDAS) – an Expert Opinion Case Study
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster I: Clinical Trial Design and Current Therapies- 9:00AM-11:00AM
-
Abstract Number: 860
Assessment of the Frequency of Cardiovascular Risk Factors in Patients with Takayasu’s Arteritis
Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 879
Associated Inflammatory Diseases in Takayasu’s Arteritis: The Many Faces of a Disease